Scholars Central

Conference abstractPublished 17 Oct 2016

The value of measurement of circulating tumor cells in hepatocellular carcinoma

Authors: Fatma Khalaf, Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Enas A Khattab

National Liver Institute-Menoufia University, Egypt; Cairo University, Egypt; Fayoum University, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background & Aim: Liver cancer is the fifth most common cancer in men and the seventh in women. During the past 20 years, the incidence of HCC has tripled while the five year survival rate has remained below 12%. The presence of circulating tumor cells (CTCs) reflects the aggressive nature of the tumor during the development of the HCC. CTCs detection and identification can be used to estimate prognosis and may serve as an early marker to assess antitumor activity of treatment. CTCs are an interesting source of biological information in order to understand dissemination, drug resistance and treatment-induced cell death. The aim is to estimate the CTCs (AFP mRNA & TGF-Ã?²1 mRNA) in the peripheral blood of patients with HCC as an early non-invasive marker of HCC detection and prognosis. Patients & Methods: The study was done on 100 patients, 58 patients with hepatocellular carcinoma (HCC), 42 patients with liver cirrhosis (LC) and 20 healthy volunteers as a control group. Detailed clinical history and examination were carried out. Complete blood count, liver function test, serum Albumin, serum AFP, AFP mRNA, serum TGF-Ã?²1 and TGF-Ã?²1 mRNA were measured. Abdominal ultrasound was done for all studied subjects and CT scan abdomen for those with HCC to determine the size and number of tumor. Results: The detection rate of AFP mRNA was 39.7%, 11.9% and 5% in patients with HCC, LC and control subjects respectively with a significant expression in HCC patients compared to other groups. Also TGF-Ã?²1 mRNA expression was significantly high in HCC cases with detection rate 60.3%, 14.3% in HCC and LC respectively while it was not detected in the controls. Both CTC were correlated with Milan criteria. The serum levels of AFP and TGF-Ã?²1 was significantly higher in HCC patients. Conclusion: TGF-Ã?²1 mRNA is a more reliable marker for diagnosis of HCC and if combined with AFP mRNA yielded better prediction of HCC prognosis. Since HCC is among the cancers with worst prognosis, early diagnosis and treatment are essential for better outcome.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Hematology & Thromboembolic Diseases
  • SubjectHaematology
  • BylineArticles whose byline prints “Fatma Khalaf”
  • BylineArticles whose byline prints “Nashwa Sheble”
  • BylineArticles whose byline prints “Gehan Hamdy”
  • BylineArticles whose byline prints “Moones A Obada”
  • BylineArticles whose byline prints “Gamal Y Abouria”
  • BylineArticles whose byline prints “Enas A Khattab”